These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 27706130)

  • 1. Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.
    Sardesai S; Biniwale M; Wertheimer F; Garingo A; Ramanathan R
    Pediatr Res; 2017 Jan; 81(1-2):240-248. PubMed ID: 27706130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing a right surfactant for respiratory distress syndrome treatment.
    Ramanathan R
    Neonatology; 2009; 95(1):1-5. PubMed ID: 18832858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History of surfactant from 1980.
    Halliday HL
    Biol Neonate; 2005; 87(4):317-22. PubMed ID: 15985754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactants: past, present and future.
    Halliday HL
    J Perinatol; 2008 May; 28 Suppl 1(Suppl 1):S47-56. PubMed ID: 18446178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review.
    Ainsworth SB; Milligan DW
    Am J Respir Med; 2002; 1(6):417-33. PubMed ID: 14720029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal-derived surfactants versus past and current synthetic surfactants: current status.
    Moya F; Maturana A
    Clin Perinatol; 2007 Mar; 34(1):145-77, viii. PubMed ID: 17394936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique story in neonatal research: the development of a porcine surfactant.
    Curstedt T; Halliday HL; Speer CP
    Neonatology; 2015; 107(4):321-9. PubMed ID: 26044099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal-derived or synthetic surfactant for the treatment of neonatal respiratory distress syndrome: a review.
    Milligan DW; Ainsworth SB
    Acta Paediatr Suppl; 2001 Mar; 90(436):25-7. PubMed ID: 11332952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies: synthetic or natural surfactant. The case for natural surfactant.
    Halliday HL
    J Perinat Med; 1996; 24(5):417-26. PubMed ID: 8950721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes.
    Tridente A; De Martino L; De Luca D
    Respir Res; 2019 Feb; 20(1):28. PubMed ID: 30728009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine versus bovine surfactant therapy for RDS in preterm neonates: pragmatic meta-analysis and review of physiopathological plausibility of the effects on extra-pulmonary outcomes.
    Foligno S; De Luca D
    Respir Res; 2020 Jan; 21(1):8. PubMed ID: 31910825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.
    Engle WA;
    Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exogenous surfactant therapy: new synthetic surfactants].
    Lacaze-Masmonteil T
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S42-6. PubMed ID: 18822258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases.
    Johansson J; Curstedt T
    J Intern Med; 2019 Feb; 285(2):165-186. PubMed ID: 30357986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant aerosol treatment of respiratory distress syndrome in the spontaneously breathing premature rabbit.
    Ellyett KM; Broadbent RS; Fawcett ER; Campbell AJ
    Pediatr Res; 1996 Jun; 39(6):953-7. PubMed ID: 8725254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.